価格表

在庫・価格 : 2024年05月18日 07時46分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-IGF-I/IGF-1, Mouse, Goat-Poly, Biotin
データシート※最新のデータシートでない場合があります
BAF791 RSDアールアンドディー システムス
R&D Systems, Inc.
50 μg ¥119,000
(未発注)
追加

在庫・価格 : 2024年05月18日 07時46分 現在

Anti-IGF-I/IGF-1, Mouse, Goat-Poly, Biotin

  • 商品コード:BAF791
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥119,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Raina K et al. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model. Cancer Res. 2007 Nov;67(22):11083-91
Raina K et al
2007/01/01
Species: Mouse, Application: ELISA Development, Sample type: Homogenized Tissue PubMed
2 Wang N et al. Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases. Mol. Ther. 2009 Jul;17(7):1241-9
Wang N et al
2009/01/01
Application: ELISA Development, Sample Type: Plasma (Heparin) PubMed
3 Yamada PM et al. Evidence of a role for insulin-like growth factor binding protein (IGFBP)-3 in metabolic regulation. Endocrinology 2010 Dec;151(12):5741-50
Yamada PM et al
2010/01/01
Application: ELISA Development, Sample Type: Serum PubMed
4 Mehta HH et al. IGFBP-3 is a metastasis suppression gene in prostate cancer. Cancer Res. 2011 Aug;71(15):5154-63
Mehta HH et al
2011/01/01
Application: ELISA Development, Sample Type: Serum PubMed
5 Fletcher L et al. Spatial distribution of insulin-like growth factor binding protein-2 following hypoxic-ischemic injury. BMC Neurosci 2013;14:158
Fletcher L et al
2013/01/01
Application: ELISA detection, Sample Type: tissue homogenate PubMed
  • No.: 1
  • 文献情報:
    Raina K et al. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model. Cancer Res. 2007 Nov;67(22):11083-91
    Raina K et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: ELISA Development, Sample type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wang N et al. Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases. Mol. Ther. 2009 Jul;17(7):1241-9
    Wang N et al
    2009/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Plasma (Heparin)
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Yamada PM et al. Evidence of a role for insulin-like growth factor binding protein (IGFBP)-3 in metabolic regulation. Endocrinology 2010 Dec;151(12):5741-50
    Yamada PM et al
    2010/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Mehta HH et al. IGFBP-3 is a metastasis suppression gene in prostate cancer. Cancer Res. 2011 Aug;71(15):5154-63
    Mehta HH et al
    2011/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Fletcher L et al. Spatial distribution of insulin-like growth factor binding protein-2 following hypoxic-ischemic injury. BMC Neurosci 2013;14:158
    Fletcher L et al
    2013/01/01
  • 備考:
    Application: ELISA detection, Sample Type: tissue homogenate
  • 参照:
    PubMed